Mangalam Drugs & Organics Limited (NSE:MANGALAM)
29.75
+0.34 (1.16%)
May 25, 2026, 11:16 AM IST
Mangalam Drugs & Organics Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 7.51 | 25.89 | 11.87 | 26.88 | 19.55 |
Cash & Short-Term Investments | 7.51 | 25.89 | 11.87 | 26.88 | 19.55 |
Cash Growth | -70.98% | 118.07% | -55.84% | 37.54% | 230.26% |
Accounts Receivable | 402.97 | 390.73 | 279.44 | 465.33 | 464.9 |
Receivables | 434.66 | 401.67 | 291.1 | 465.78 | 465.26 |
Inventory | 1,028 | 1,388 | 1,236 | 1,375 | 1,171 |
Prepaid Expenses | - | 15.61 | 16.1 | 18.74 | 20.54 |
Other Current Assets | 87.21 | 158.65 | 204.53 | 179.77 | 173.92 |
Total Current Assets | 1,557 | 1,990 | 1,760 | 2,066 | 1,850 |
Property, Plant & Equipment | 1,260 | 1,336 | 1,269 | 1,336 | 1,268 |
Long-Term Investments | 0.04 | - | - | 0.04 | 0.04 |
Other Intangible Assets | 329.8 | 60.2 | 121.54 | 182.99 | 138.76 |
Long-Term Deferred Charges | - | 258.11 | 163.64 | - | - |
Other Long-Term Assets | 2.85 | 20.12 | 22.94 | 11.89 | 27.18 |
Total Assets | 3,150 | 3,664 | 3,337 | 3,596 | 3,284 |
Accounts Payable | 759.14 | 911.49 | 661.62 | 970.73 | 545.47 |
Accrued Expenses | - | 47.93 | 40.57 | 40.01 | 38.29 |
Short-Term Debt | 1,018 | 719.37 | 745.96 | 495.67 | 470.96 |
Current Portion of Long-Term Debt | - | 70.65 | 84.99 | 62.59 | 66.15 |
Current Portion of Leases | 23.61 | 54.79 | 54.09 | 72.15 | 38.77 |
Current Income Taxes Payable | - | 9.18 | - | 3.76 | 22.7 |
Current Unearned Revenue | - | 29 | 46.61 | - | - |
Other Current Liabilities | 164.77 | 73.58 | 6.78 | 8.67 | 118.81 |
Total Current Liabilities | 1,966 | 1,916 | 1,641 | 1,654 | 1,301 |
Long-Term Debt | 74.98 | 92.33 | 133.54 | 187.66 | 251.03 |
Long-Term Leases | 10.66 | 25.16 | 51.34 | 67.39 | 52.14 |
Pension & Post-Retirement Benefits | - | 13.54 | 19.28 | 22.93 | 39.39 |
Long-Term Deferred Tax Liabilities | 52.01 | 98.15 | 120.86 | 145.16 | 134.95 |
Other Long-Term Liabilities | 15.65 | 29.25 | 13.45 | 0 | 0.01 |
Total Liabilities | 2,119 | 2,174 | 1,979 | 2,077 | 1,779 |
Common Stock | 158.28 | 158.28 | 158.28 | 158.28 | 158.28 |
Additional Paid-In Capital | - | 223.75 | 223.75 | 223.75 | 223.75 |
Retained Earnings | - | 1,037 | 975.89 | 1,141 | 1,128 |
Comprehensive Income & Other | 872.31 | 70.81 | - | -3.02 | -4.27 |
Shareholders' Equity | 1,031 | 1,490 | 1,358 | 1,520 | 1,506 |
Total Liabilities & Equity | 3,150 | 3,664 | 3,337 | 3,596 | 3,284 |
Total Debt | 1,128 | 962.3 | 1,070 | 885.47 | 879.04 |
Net Cash (Debt) | -1,120 | -936.41 | -1,058 | -858.58 | -859.5 |
Net Cash Per Share | -70.76 | -59.16 | -66.85 | -54.24 | -54.30 |
Filing Date Shares Outstanding | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 |
Total Common Shares Outstanding | 15.83 | 15.83 | 15.83 | 15.83 | 15.83 |
Working Capital | -408.69 | 73.84 | 119.39 | 412.27 | 549.19 |
Book Value Per Share | 65.12 | 94.12 | 85.79 | 96.00 | 95.12 |
Tangible Book Value | 700.79 | 1,430 | 1,236 | 1,337 | 1,367 |
Tangible Book Value Per Share | 44.28 | 90.32 | 78.11 | 84.44 | 86.36 |
Land | - | 86.62 | 11.29 | 5.44 | 5.44 |
Buildings | - | 374.79 | 371.23 | 370.13 | 369.83 |
Machinery | - | 1,836 | 1,661 | 1,604 | 1,592 |
Construction In Progress | - | - | - | 64.04 | 1.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.